Recorded noted regulatory successes with FDA general use clearance and granting of CE Mark in the EUAdvanced commercialization globally, signing ...
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14 A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14 A INFORMATION Proxy Statement Pursuant to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果